As marijuana is finally being recognized as a medicine in the last decades, Canada is slowly building reputation as a cannabis friendly country by funding the international cannabis industry.
“We are not going to be dipping our toes into international waters,” said Cam Battley, Executive Vice President of Aurora Cannabis, “Each market we enter, we are going to be a significant and long-term player.”
He also mentioned company’s 19.9 percent stake in Australia’s Cann Group. “[Cann Group] was the first company to be licensed to conduct research and cultivate medical cannabis. They are building two facilities right now.”
Battley added that Aurora was recently visited by Australian Minister of Agriculture for the State of Victoria, Jaala Pulford. “[Minister Pulford] was very clear that she wanted to learn from Canada’s experience and Canada’s leadership in this space.”
Canadian pot also helped Germany to prosper on that field. “In Germany we acquired Pedanios, which is the largest medical cannabis distributor in Germany,” said Battley. “This is a major strategic investment for us, and it anchors us in Germany.” Aurora intends to be a domestic licensed producer in the German market through the acquisition of Pedanios.
Beside Aurora, Canopy Growth is to expanding its business. That company is already operating in some other countries including Australia, Germany, Brazil, and most recently Chile.
“[Canada] is a comparatively small market, but it’s the place where everything is being proven,” said Jordan Sinclair, Director of Communications for Canopy Growth “We’ve got a country of 35 million people, which on the world stage isn’t significant from a population perspective. But for cannabis, because of the federal laws we are in a leadership role.”
Jordan agrees with his colleagues from other licensed producers on position that Canada is at the center of the funding and growth of the global cannabis industry. “The finance world in Canada is very much at the cutting edge of what you call the globalization of the cannabis industry.”
Jordan also mentioned that that not only Canadian dollars dominate the cannabis industry, but Canadian pot itself is being influental on worldwide cannabis market. For him that is the intellectual property that Canadian LPs bring to the table. “Canopy has already proven this model once by partnering with Auscann in Australia. The ingenuity that’s coming out of this is really positioning us to have the global expertise. Now when people think about the cannabis we ship in the world, they immediately start thinking about Canada.”
Another Canadian company that is important on international level is PharmaCielo, it has deep roots in growing in Colombian cannabis.
“[This] is an important undertaking for Colombia as a nation,” said Spokesperson for PharmaCielo, David Gordon “The government down there has demonstrated real leadership in the [cannabis] space.”
They are currently preparing to grow their crops in Colombia, and of the goals is exporting it to other countries with legalized cannabis. “We are preparing for cultivation. It was [over] a year ago that PharmaCielo was the first recipient [in Colombia] of a license for the manufacture and processing. Since that time, we have commenced on developing the infrastructure to allow both manufacturing and processing, as well as to allow cultivation.”
David also added, “In terms of shipping, once [the cannabis] is processed we’ll be looking at as many markets as are open and available at the time. Colombia is included in that, and then internationally.”